carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastična sredstva - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
lenalidomid sandoz 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 25 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid
lenalidomid teva 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid
lenalidomid teva 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenalidomid teva 25 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid
lenalidomid teva 5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid
lenalidomid grindeks 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid